Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1989-03-31
1991-10-22
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61K 3150, A61K 31495
Patent
active
050596004
ABSTRACT:
A method for teating habit disorders in a human patient comprising administering to the patient an anti-habitual amount of a pharmaceutically active compound, which results in activation of a brain reward system, e.g., flupenthixol, or esters thereof or pharmaceutically acceptable salts thereof, either alone or in admixture with a physiologically acceptable diluent.
REFERENCES:
Epidemic Free-Base Cocaine Abuse; James F. Jekel, the Lancet, Mar. 1986, pp. 459-462, vol. 1.
Cocaine and Other Stimulants; Frank H. Gawin, M.D., vol. 318, No. 18, pp. 1173-1182, New England Journal of Medicine, 1988.
Evolving Conceptualizations of Cocaine Dependence; Frank H. Gawin, the Yale Journal of Biology and Medicine Inc., pp. 123-136, 1988.
Abstinence Symptomatology and Psychiatric Diagnosis in Cocaine Abusers; F. Gawin & H. Kleber; Arch. Gen. Phychiatry, vol. 43, Feb. 1986, pp. 107-113.
Desipramine Facilitation of Initial Cocaine Abstinence, F. Gawin & H. Kleber; Arch. Gen. Phychiatry, vol. 46, Feb. 1989, pp. 117-121.
Depression-Inducing and Antidepressive Effects of Neuroleptics, Neuropsychobilogy 10: pp. 131-136, Poldinger S. Sieberns (1983).
Flupenthixol Decanoate in Schizophrenia; H. R. Trueman & M. G. Valentine; Brit. F. Psychiat. (1974), 124, pp. 58-59.
Major Tranquilizers Used as Antidepressants, Mary M. Robertson & M. R. Trimble, Journal of Affective Disorders, 4(1982) pp. 173-193; Elsevier Biomedical Press.
A Controlled Comparison of Flupenthixol and Amitriptyline in Depressed Outpatients; J. Young, British Medical Journal, 1976, pp. 1116-1118, vol. 1.
SCRIP No. 822, Aug. 22, 1983, p. 2.
Central Nervous System, p. 78.
The Merck Index, pp. 559-600.
Lundbeck Limited, pp. 684-685.
Chemindex Plug, p. 407.
Symptomatic Relief with Flupentixol (Fluanxol) of the Anxious-Aletic-Depressive Syndrome Complex in Neurotic States; V. Predescu; Acta Psychiat. Scand (1973) 49, pp. 15-27.
A Double-Blind Comparison of Flupenthixol, Nortriptyline and Diazepam in Neurotic Depression; D. Johnson; Acta Psychiat. Scand. (1979) 59, pp. 1-8.
Objective and Subjective Assessments of the Effects of Flupentixol and Benzodiazepines on Human Psychomotor Performance; M. Mattila Psychopharmacology (1988) 95: pp. 323-328.
Flupenthixol Versus Combined Fluphenazine-Nortriptyline in Depressive Illness; Mar. 1981, vol. 225, J. Conway, pp. 400-404.
Repeated Cocaine Administration Results in Supersensitivity of Striatal D-2 Dopamine Autoreceptors to Pergolide, Linda Dwoskin; 1988 Pergamon Journals Ltd.; Life Sciences, vol. 42, pp. 225-262.
A Controll Comparison of Flupenthixol Decanoate Infections and Oral Amitriptyline in Depressed Out-Patients; W. Tam Young; Brit. J. Psychiat, (1982), 140, pp. 287-291.
Allen David F.
Gawin Frank H.
Humblestone Brian G.
Friedman Stanley J.
Yale University
LandOfFree
Treating habit disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treating habit disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating habit disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-108672